Myomo (MYO) Earnings Dates, Call Summary & Reports

Q: When does Myomo Inc (MYO) report earnings?

Myomo Inc (MYO) is schdueled to report earning on Mar 16, 2026, After Close (Confirmed).

Q: What is Myomo Inc (MYO) earnings time?

Myomo Inc (MYO) earnings time is at Mar 16, 2026, After Close (Confirmed).

Q: Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

Q: What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

Q: What is MYO EPS forecast?

MYO EPS forecast for the fiscal quarter 2025 (Q4) is -0.08.

Compare

542 Followers

Earnings Data

Report Date

Mar 16, 2026

After Close (Confirmed)

Period Ending

2025 (Q4)

Consensus EPS Forecast

-0.08

Last Year’s EPS

-0.01

Same Quarter Last Year

Analyst Consensus

Strong Buy

Based on 4 Analysts Ratings

Earnings Call Summary

Q3 2025

Earnings Call Date:Nov 10, 2025|

% Change Since:

Earnings Call Sentiment|Neutral

The earnings call presented a mixed picture with notable revenue growth and strategic expansions, particularly in international markets and the O&P channel. However, challenges such as decreased gross margin, increased operating loss, and high cash burn were significant concerns. The company's reaffirmation of financial guidance and steps to optimize costs and advertising were positive, but the issues with Medicare Advantage revenue and increased losses present challenges.

Company Guidance

During the Myomo Third Quarter 2025 Financial Results Conference Call, CEO Paul Gudonis provided guidance that the company anticipates achieving full-year 2025 revenue within the range of $40 million to $42 million, reflecting an over 23% increase compared to the previous year. This optimistic outlook is supported by a robust performance in the third quarter, where the company reported revenues of $10.1 million, driven by a 16% increase in MyoPro revenue units and strong international sales, notably a 63% rise in Germany. Additionally, the company is expanding its MyoConnect program and O&P channel to lower customer acquisition costs while also seeing a positive trend in Medicare Advantage authorizations. Myomo's strategic initiatives include expanding insurance coverage, reducing operating costs, and enhancing patient identification processes. CFO Dave Henry highlighted a gross margin of 63.8% and operating expenses totaling $10 million, with a focus on improving operating leverage and lowering cash burn in 2026. The company reiterated its commitment to scaling its business towards sustainable profitability and positive cash flow.

Revenue Growth and International Success

Myomo reported a revenue of $10.1 million for Q3 2025, marking a 10% increase compared to the prior year, driven by record revenues in international markets, especially Germany.

Increased Authorizations and Orders

For the first time this year, Myomo saw a sequential increase in quarterly authorizations and orders, supported by more Medicare Advantage payer authorizations.

Expanding O&P Channel

Revenue from the O&P channel increased by 154% year over year, reaching $900,000. The international revenue, particularly from Germany, was a record $1.8 million, up 63%.

Cost Reduction and Operating Leverage

Steps were taken to reduce operating costs and improve gross margin, along with plans to optimize advertising spend and expand the MyoConnect program.

Financial Guidance Reaffirmed

Myomo reiterated its full 2025 annual guidance of $40 million to $42 million in revenue, representing an increase of more than 23% over the previous year.

Myomo (MYO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MYO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 16, 2026	2025 (Q4)	-0.08 / -	-0.01	―	―	―
Nov 10, 2025	2025 (Q3)	-0.11 / -0.09	-0.03	-200.00% (-0.06)	―
Aug 11, 2025	2025 (Q2)	-0.11 / -0.11	-0.03	-266.67% (-0.08)	―
May 07, 2025	2025 (Q1)	-0.08 / -0.08	-0.1	20.00% (+0.02)	―
Mar 10, 2025	2024 (Q4)	-0.02 / -0.01	-0.07	85.71% (+0.06)	―
Nov 06, 2024	2024 (Q3)	-0.04 / -0.03	-0.06	50.00% (+0.03)	―
Aug 06, 2024	2024 (Q2)	-0.07 / -0.03	-0.04	25.00% (+0.01)
May 08, 2024	2024 (Q1)	-0.10 / -0.10	-0.11	9.09% (<+0.01)
Mar 07, 2024	2023 (Q4)	-0.06 / -0.07	-0.29	75.86% (+0.22)	―
Nov 07, 2023	2023 (Q3)	-0.09 / -0.06	-0.4	85.00% (+0.34)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MYO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 10, 2025	$0.92	$0.85	-7.61%
Aug 11, 2025	$1.76	$1.08	-38.64%
May 07, 2025	$4.84	$3.36	-30.58%
Mar 10, 2025	$4.17	$5.87	+40.77%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.